These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 14971862

  • 1. Imipramine vs. sertraline in panic disorder: 24-week treatment completers.
    Mavissakalian MR.
    Ann Clin Psychiatry; 2003; 15(3-4):171-80. PubMed ID: 14971862
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The side effects burden of extended imipramine treatment of panic disorder.
    Mavissakalian MR, Perel JM.
    J Clin Psychopharmacol; 2000 Oct; 20(5):547-55. PubMed ID: 11001240
    [Abstract] [Full Text] [Related]

  • 5. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.
    Mavissakalian MR, Perel JM, Talbott-Green M, Sloan C.
    Biol Psychiatry; 1998 Jun 01; 43(11):848-54. PubMed ID: 9611676
    [Abstract] [Full Text] [Related]

  • 6. Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials.
    Chawla N, Anothaisintawee T, Charoenrungrueangchai K, Thaipisuttikul P, McKay GJ, Attia J, Thakkinstian A.
    BMJ; 2022 Jan 19; 376():e066084. PubMed ID: 35045991
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A 15-year follow-up study of patients with panic disorder.
    Andersch S, Hetta J.
    Eur Psychiatry; 2003 Dec 19; 18(8):401-8. PubMed ID: 14680716
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sertraline treatment of panic disorder: response in patients at risk for poor outcome.
    Pollack MH, Rapaport MH, Clary CM, Mardekian J, Wolkow R.
    J Clin Psychiatry; 2000 Dec 19; 61(12):922-7. PubMed ID: 11206597
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study.
    Bertani A, Perna G, Arancio C, Caldirola D, Bellodi L.
    J Clin Psychopharmacol; 1997 Apr 19; 17(2):97-101. PubMed ID: 10950471
    [Abstract] [Full Text] [Related]

  • 16. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
    Sussman N, Ginsberg DL, Bikoff J.
    J Clin Psychiatry; 2001 Apr 19; 62(4):256-60. PubMed ID: 11379839
    [Abstract] [Full Text] [Related]

  • 17. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A, Coutu MF, Dupuis G, Fleet R, Borgeat F, Todorov C, Mainguy N.
    Cogn Behav Ther; 2008 Apr 19; 37(3):146-59. PubMed ID: 18608313
    [Abstract] [Full Text] [Related]

  • 18. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
    Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB.
    Am J Psychiatry; 2000 Sep 19; 157(9):1445-52. PubMed ID: 10964861
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rational treatment of panic disorder with antidepressants.
    Mavissakalian MR, Ryan MT.
    Ann Clin Psychiatry; 1998 Dec 19; 10(4):185-95. PubMed ID: 9988061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.